"Designing Growth Strategies is in our DNA"

Opioid Use Disorder (OUD) Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies) and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI102674

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Pipeline Analysis
    2. New Product Launches
    3. Statistics of Opioid Use Disorder
    4. Industry Developments Such as Mergers, Acquisitions, and Collaborations
  5. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
    5. Market Analysis – By Country
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis – By Drug Class
      1. Buprenorphine
      2. Methadone
      3. Naltrexone
    3. Market Analysis – By Route of Administration
      1. Oral
      2. Parenteral
    4. Market Analysis – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies & Stores
      3. Online Pharmacies
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Indivior PLC
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Alkermes
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Orexo US, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Titan Pharmaceuticals Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. TEVA PHARMACEUTICALS USA, INC
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Mallinckrodt
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. BioDelivery Sciences International Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Mylan
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Hikma Pharmaceuticals
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Camurus
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      12. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  11. Strategic Recommendations
Read Less

Figure 1:  Global Opioid Use Disorder (OUD) Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 2:  Global Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2020 & 2028

Figure 3:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Buprenorphine, 2017-2028

Figure 4:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Methadone, 2017-2028

Figure 5:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Naltrexone, 2017-2028

Figure 6:  Global Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2020 & 2028

Figure 7:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Oral, 2017-2028

Figure 8:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Parenteral, 2017-2028

Figure 9:  Global Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 10:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Hospitals Pharmacies, 2017-2028

Figure 11:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Retail Pharmacies & Stores, 2017-2028

Figure 12:  Global Opioid Use Disorder (OUD) Market Forecast (USD billion), by Online Pharmacies, 2017-2028

Figure 13:  Global Opioid Use Disorder (OUD) Market Value (USD billion), by Region, 2020 & 2028

Figure 14:  North America Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 15:  North America Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2020

Figure 16:  North America Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2020 & 2028

Figure 17:  North America Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2020

Figure 18:  North America Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 19:  North America Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2020

Figure 20:  North America Opioid Use Disorder (OUD) Market Value (USD billion), By Country, 2020 & 2028

Figure 21:  North America Opioid Use Disorder (OUD) Market Value Share (%), By Country, 2020

Figure 22:  Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 23:  Europe Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2020

Figure 24:  Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2020 & 2028

Figure 25:  Europe Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2020

Figure 26:  Europe Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 27:  Europe Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2020

Figure 28:  Europe Opioid Use Disorder (OUD) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 29:  Europe Opioid Use Disorder (OUD) Market Value Share (%), By Country/ Sub-region, 2020

Figure 30:  Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 31:  Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2020

Figure 32: Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2020 & 2028

Figure 33:  Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2020

Figure 34:  Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 35:  Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2020

Figure 36:  Asia Pacific Opioid Use Disorder (OUD) Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 37:  Asia Pacific Opioid Use Disorder (OUD) Market Value Share (%), By Country/ Sub-region, 2020

Figure 38:  Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 39:  Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Drug Class, 2020

Figure 40:  Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Route of Administration, 2020 & 2028

Figure 41:  Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Route of Administration, 2020

Figure 42:  Rest of the World Opioid Use Disorder (OUD) Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 43:  Rest of the World Opioid Use Disorder (OUD) Market Value Share (%), by Distribution Channel, 2020

Figure 44:  Global Opioid Use Disorder (OUD) Market Share (%), By Company, 2020

Table 1:  Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017–2028

Table 2:  Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017–2028

Table 3:  Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017–2028

Table 4:  Global Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 5:  North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 6:  North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017-2028

Table 7:  North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 8:  North America Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country, 2017-2028

Table 9:  Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 10:  Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017-2028

Table 11:  Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 12:  Europe Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 13:  Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 14:  Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017-2028

Table 15:  Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 16:  Asia Pacific Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 17:  Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 18:  Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017-2028

Table 19:  Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 20:  Rest of the World Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 21:  Middle East & Africa Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 22:  Middle East & Africa Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Route of Administration, 2017-2028

Table 23:  Middle East & Africa Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 24:  Middle East & Africa Opioid Use Disorder (OUD) Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

  • May, 2021
  • 2020
  • 2017-2019
  • 137

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X